Release Date: August 29, 2025
Expiration Date: August 29, 2026
Activity Overview
X-linked retinitis pigmentosa (XLRP), which commonly results from mutations in the RPGR gene or the RP2 gene, is frequently more severe than other forms of retinitis pigmentosa. The onset of legal blindness occurs decades earlier in male patients than in those with other forms of RP; in addition, female XLRP carriers can also be severely affected. In this program, a multispecialty panel provides expert insights into the diagnosis of XLRP, team-based management, and developments in investigational gene therapies for XLRP.
This educational activity is an archive of the live virtual symposium held on July 31, 2025.
Target Audience
This educational curriculum is directed toward retina specialists, ophthalmologists, low vision specialists, optometrists, pediatric ophthalmologists, genetic counselors, and other health care professionals who treat patients with inherited retinal diseases.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Integrate clinical and genetic findings to establish a diagnosis of XLRP
- Outline the roles for eye care professionals and clinical geneticists/genetic counselors in the management of patients with XLRP
- Develop multidisciplinary management plans for patients with XLRP based on clinical presentation and goals of therapy
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here